Ensign Peak Advisors’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $6.1M | Sell |
|
|||||
|
2025
Q2 | $6.4M | Buy |
|
|||||
|
2025
Q1 | $7.7M | Buy |
|
|||||
|
2024
Q4 | $2.42M | Buy |
|
|||||
|
2024
Q3 | $1.71M | Hold |
|
|||||
|
2024
Q2 | $1.2M | Hold |
|
|||||
|
2024
Q1 | $929K | Sell |
|
|||||
|
2023
Q4 | $1.26M | Hold |
|
|||||
|
2023
Q3 | $1.06M | Hold |
|
|||||
|
2023
Q2 | $862K | Hold |
|
|||||
|
2023
Q1 | $839K | Buy |
|
|||||
|
2022
Q4 | $762K | Buy |
|
|||||
|
2022
Q3 | $718K | Sell |
|
|||||
|
2022
Q2 | $921K | Hold |
|
|||||
|
2022
Q1 | $873K | Hold |
|
|||||
|
2021
Q4 | $767K | Sell |
|
|||||
|
2021
Q3 | $1.72M | Hold |
|
|||||
|
2021
Q2 | $1.92M | Buy |
|
|||||
|
2021
Q1 | $2.04M | Buy |
|
|||||
|
2020
Q4 | $1.37M | Buy |
|
|||||
|
2020
Q3 | $600K | Hold |
|
|||||
|
2020
Q2 | $580K | Hold |
|
|||||
|
2020
Q1 | $410K | Buy |
|